TOPIC 22 – Heart failure, cardiomyopathies – D  by unknown
Archives of Cardiovascular Diseases Supplements (2012) 2, 1-84 55
© Elsevier Masson SAS. All rights reserved.
 TOPIC 22 – Heart failure, 
cardiomyopathies – D
April 13th, Friday 2012
0197
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Background: Cardiac Resynchronization Therapy (CRT) by biventricular 
pacing (BIV- P) is an ef¿ cient treatment in symptomatic patients with severe 
impairment of left ventricular ejection fraction (LVEF) and left bundle branch 
block (LBBB) despite optimal medical therapy (OMT). However, left ven-
tricular pacing alone (LV- P) seems to be as effective with less material to 
implant (double chamber device with atrial and left ventricular leads). The aim 
of this study is to analyze the reponse of patients undergoing CRT by LV- P 
device after one year follow- up.
Method: We studied retrospectively 69 patients (67% male, 69±8 years, 
LVEF 23±7%) who received a LV- P device for severe heart failure (class III 
to IV NYHA) despite OMT, in sinus rhythm with LBBB and no conventional 
indication for pacing. Outcome of NYHA class, LVEF and cardiopulmonary 
exercise testing parameters (VO2 peak, compared VE/VCO2 and circulatory 
power) were followed at one year.
Results: After one year follow- up six deaths was reported and ¿ ve 
patients was lost to follow- up. The percentage of responders de¿ ned by a 
functional improvement of at least one NYHA class, was 78%. The average 
decrease in NYHA class was 1.36±0.8 (p<0.0001). An increase in LVEF 
(14.7±13.4%; p<0.0001), Peak VO2 (1.4±2.9ml/min/kg; NS) and circulatory 
power (322±504; p=0.035) was observed. The slope VE/VCO2 decreased of 
10.15±10.8 (p=0.0009).
Conclusion: CRT by LV- P improves patients signi¿ cantly with regard 
to NYHA class, LVEF and cardiopulmonary exercise testing parameters in 
patients with decreased LVEF, LBBB and severe heart failure. Compared to 
pubished data, LV- P seems to be as ef¿ cient as BIV- P in these patients.
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Sepsis- associated myocardial dysfunction is one of the main causes of mor-
tality in critically ill patients, for which no ef¿ cacious therapies exist. We 
recently showed that PTP1B gene deletion affords myocardial protection in 
experimental heart failure. However, whether PTP1B inactivation opposes 
sepsis- associated myocardial dysfunction is unknown. Thus, we assessed the 
effect of PTP1B gene deletion on left ventricular (LV) function and inÀ am-
mation in mice with endotoxinic shock (induced by intraperitoneal injection 
of lipopolysaccharide, (LPS) followed by a subcutaneous À uid resuscitation). 
LV function was evaluated in vivo by echocardiography and pressure- volume 
curves, and ex- vivo in Langendorff isolated- perfused hearts. Plasma and left 
ventricular samples were collected to measure the production of inÀ ammatory 
cytokines by Elisa multiplex assay and real- time RT- PCR. 
Compared to wild type (WT), PTP1B- /- mice showed a marked decrease 
in mortality (30% vs. 100%, n=20). In WT mice, LPS induce a severe LV 
dysfunction 8 hours (H8) after LPS injection, shown by the decreased frac-
tioning shortening (H0: 49±1%; H8 18±1%, p<0.01) which was improved in 
PTP1B- /- mice (24±1%, p<0.01). In WT mice, this LV dysfunction was asso-
ciated with a signi¿ cant PTP1B overexpression.
PTP1B deletion also prevented the LPS- induced increase in the relaxation 
constant Tau (WT H8 8.8±0.6ms; PTP1B- /- H8 6.8±0.3ms, p<0.01) and in 
the slope of the LV end- diastolic pressure- volume relation (WT H8 4.7±0.8; 
PTP1B- /- H8 2.38±0.3, p<0.01).
The improvement of LV function in PTP1B- /- mice was associated with a 
signi¿ cant decrease in myocardial inÀ ammation, despite a systemic enhance-
ment of TNF- α and Il- 1β production. In conclusion, we demonstrate for the ¿ rst 
time that PTP1B play a potential role in LPS- induced LV dysfunction and that 
its inhibition could be a new treatment of the myocardial dysfunction in sepsis.
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Background: Hypoxic states of the cardiovascular system are often asso-
ciated with frequent heart diseases of modern time. In this study, modi¿ cations 
of heart energetics induced by chronic hypoxia (CH) were studied under condi-
tions of high oxygen deprivation in order to understand the speci¿ c hypoxic 
resistance encountered after physiological adaptation to chronic hypoxia. 
Methods: Swiss mice were exposed to a simulated altitude of 5500m in a 
barochamber for 21 days. The effects of a decreased oxygen concentration in 
the perfusate (low PO2: 100/120mmHg) on contractile performance (RPP) and 
phosphocreatine (PCr) concentration (assessed by 31P- NMR) were studied 
in isolated perfused hearts. Results were analyzed using Modular Control 
Analysis (MoCA), describing the integrative changes in cardiac energetics 
regulation induce by acute hypoxia. 
Results: CH hearts energetics was insensitive to the severe oxygen reduc-
tion unlike Control hearts for which concomitant decreases in RPP (- 46%) and 
in [PCr] (- 23%) were observed. This absence of change was explained by a 
higher sensitivity of energy supply for CH hearts (elasticity coef¿ cients: - 1.88 
for CH vs - 0.89 for Controls, p<0.01) measured under low oxygen perfusion. 
Indeed, CH hearts exhibited an improved energy supply response to energy 
demand, resulting in the conservation of a healthy control pattern of contrac-
tion despite oxygen deprivation.
Conclusions: As suggested by the present study, the positive adaptation 
of CH hearts to oxygen deprivation could participate in the improvement of 
cardiac energetics, speci¿ cally at the level of energy supply by mitochondria. 
Since alteration of the energetic system could induce severe organ dysfunc-
tion, adaptation to hypoxia may limit the damages induced by acute hypoxia 
observed in multiple pathologies.
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Cardiac Resynchronization Therapy reduces metaboreÀ ex contribu-
tion to the ventilatory response in heart failure population
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Background: MetaboreÀ ex overactivation has been proprosed to partly 
explain exaggerated hyperventilation (high VE/VCO2 slope) in heart failure 
population during exercise. Cardiac resynchronization therapy (CRT) is a 
major treatment for patients suffering from refractory heart failure improving 
the ventilatory reponse during exercise.
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Aims: To investigate the metaboreÀ ex activation as a potential pathophysio-
logical explanation in the improvement of the ventilatory response after CRT. 
Methods and results: 10 heart failure patients (mean left ventricular ejection 
(LVEF) 27±4%, peak VO2 14±4ml/kg/min, NYHA class 2.4±0.5) schedulded 
for CRT implantation were prospectively studied. At baseline and after 6 month 
follow up two maximal cardiopulmonary exercise tests with and without 
regional circulatory occlusion (RCO) during recovery were performed. RCO 
was achieved by inÀ ation of bilateral upper thigh tourniquets 30mmHg above 
peak systolic blood pressure during 3 minutes after peak exercise. MetaboreÀ ex 
contribution to the ventilatory response was assessed as the difference in ven-
tilatory data at the third minute during recovery between the two tests (Δ). At 
baseline, patients had enhanced VE/VCO2 slope (40±9) and an evident meta-
boreÀ ex contribution to the high ventilatory response (ΔVE: 3±4 L/min; p=0.05, 
ΔRR: 4.5±4/min; p=0.003 and ΔVE/VCO2: 5.5±4; p=0.007). 6 months after 
CRT implantation, NYHA class, LVEF, peak VO2 and VE/VCO2 were signi-¿ cantly improved (1.4±0.5; p<0.001, 42±7%; p<0.001, 16.5±3ml/kg/min; 
p=0.003; 33±10; p=0.01). MetaboreÀ ex contribution to VE, RR and VE/VCO2 
was reduced compared with baseline (p=0.08, p=0.01 and p=0.4 respectively).
Conclusion: 6 months after CRT metaboreÀ ex contribution to the ventila-
tory response is reduced.
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Background: MetaboreÀ ex overactivation has been proprosed to partly 
explain exaggerated hyperventilation (high VE/VCO2 slope) in heart failure 
population during exercise. Cardiac resynchronization therapy (CRT) is a 
major treatment for patients suffering from refractory heart failure improving 
the ventilatory reponse during exercise.
Aims: To investigate the metaboreÀ ex activation as a potential pathophy-
siological explanation in the improvement of the ventilatory response after 
CRT. 
Methods and results: 10 heart failure patients (mean left ventricular ejection 
(LVEF) 27±4%, peak VO2 14±4ml/kg/min, NYHA class 2.4±0.5) schedulded 
for CRT implantation were prospectively studied. At baseline and after 6 month 
follow up two maximal cardiopulmonary exercise tests with and without 
regional circulatory occlusion (RCO) during recovery were performed. RCO 
was achieved by inÀ ation of bilateral upper thigh tourniquets 30mmHg above 
peak systolic blood pressure during 3 minutes after peak exercise. MetaboreÀ ex 
contribution to the ventilatory response was assessed as the difference in ven-
tilatory data at the third minute during recovery between the two tests (Δ). At 
baseline, patients had enhanced VE/VCO2 slope (40±9) and an evident meta-
boreÀ ex contribution to the high ventilatory response (ΔVE: 3±4 L/min; p=0.05, 
ΔRR: 4.5±4/min; p=0.003 and ΔVE/VCO2: 5.5±4; p=0.007). 6 months after 
CRT implantation, NYHA class, LVEF, peak VO2 and VE/VCO2 were signi-¿ cantly improved (1.4±0.5; p<0.001, 42±7%; p<0.001, 16.5±3ml/kg/min; 
p=0.003; 33±10; p=0.01). MetaboreÀ ex contribution to VE, RR and VE/VCO2 
was reduced compared with baseline (p=0.08, p=0.01 and p=0.4 respectively).
Conclusion: 6 months after CRT metaboreÀ ex contribution to the ventila-
tory response is reduced.
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Introduction: Endothelin (ET) plasma concentrations are of prognostic 
value in heart failure (HF), but remain increased in humans even when 
treated with ACE inhibitors. Both dual ETA- ETB or selective ETA receptor 
antagonists abrogate the deleterious effects of ET, i.e. vasoconstriction and 
adverse left ventricular (LV) remodeling in experimental HF, but only dual 
ETA- ETB receptor antagonists increase in survival in experimental HF. In 
contrast, in humans with CHF neither ETA nor dual ETA- ETB receptor anta-
gonists improve long- term survival, despite bene¿ cial hemodynamic effects. 
Endothelin converting enzyme (ECE) inhibition might be a therapeutic alter-
native for ET receptor blockade, but whether ECE- inhibition exerts bene¿ cial 
effects in HF is unknown. Thus, we studied the effect of ECE inhibition on LV 
function and structure in CHF. 
Method: In Wistar rats with coronary artery ligation (CAL), LV hemo-
dynamics and remodeling as well as LV tissue perfusion were assessed by 
LV catheterization, echocardiography and MRI after treatment with the selec-
tive ECE inhibitor LF1437213 (10mg/kg/day for 1 month starting 7 days after 
CAL) or placebo. Results: CAL induced classical signs of HF, i.e. decreased 
LV end- systolic pressure (LVESP) and LVESP- volume relation and increased 
LV end- diastolic pressure (LVEDP) as well as LVEDP- volume relation, asso-
ciated with increased LV diastolic diameter and reduced cardiac output (CO) 
and LV tissue perfusion. Compared to placebo treated HF animals, LF1437213 
reduced LVESP, LVEDP as well as LVEDP- volume relation and increased 
LVESP- volume relation, while CO and LV tissue perfusion were increased. 
Moreover, LF1437213 reduced LV diastolic diameter and LV collagen density 
but not LV hypertrophy. 
Conclusion: ECE inhibition reduces LV pre- and afterload prevents LV 
remodeling and improves LV perfusion as well as function, demonstrating the 
potential interest of ECE inhibition for the treatment of HF. Key words: Heart 
failure, ECE, ET
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Prevalence of heart failure (HF) is growing because of the ageing of the 
populations and the increase of the cardiovascular risk factors. Blood HF bio-
markers such as the natriuretic peptides (NP) have been proposed. However, 
the NP biomarker family has limitations and HF diagnosis remains too often 
complicated because of atypical presentations and the need of specialized care 
access. More speci¿ c and accurate biomarkers with detection method allowing 
for facilitated large scale HF screenings are required. Indeed, 30% of the 
patients admitted to emergency care for acute dyspnea have a BNP concentra-
tion in a « grey zone » that do not allow for diagnosis. Thus, diagnosis of these 
patients is costly and time- consuming while a rapid medical care of the patient 
has a positive impact on his health and reduces the treatment cost. Therefore, 
we have launched a prospective monocentric case- control study and investi-
gated for urinary polypetides speci¿ c to acute (AHF) or chronic heart failure 
(CHF), using a capillary electrophoresis- mass spectroscopy strategy (CE- 
MS). Based on a ¿ rst screen of the urinary proteome of 50 patients (9 CHF, 13 
AHF, 28 healthy controls matched for cardiovascular risk factors), we revealed 
a panel of polypeptides speci¿ c to HF (77 discriminant polypeptides, out of 
these 9 with AUC>0.92; p<0.05 after correction). We also observed a speci¿ c 
pro¿ le for CHF (8 polypeptides with AUC>0.92; p<0.05 after correction) and 
another pro¿ le for AHF (11 polypeptides with AUC>0.89 ; p<0.05 after cor-
rection). One polypeptide (x64054) seemed very relevant because it could dis-
criminate AHF and CHF with a high speci¿ city and speci¿ city (AUC= 0.99 ; 
p<0.0001). We now aim at the validation of these putative biomarkers in a 
larger study enrolling 200 patients (50 per group), comprising 50 with a BNP 
level in the “grey zone”. Optimized methods will be used to measure urinary 
peptides in 350 patients admitted for acute dyspnea at the hospital emergency 
care unit. Our work should provide with new biomarkers allowing for HF dia-
gnosis in the BNP « grey zone » and therefore allow for a better care of the HF 
patients at the hospital but also in general care. Moreover, the study of the new 
peptides could propose new pathways and regulations involved in HF patho-
physiology and led to innovative therapeutic strategies. 
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The cardiovascular alteration in the septic shock include an hypotension asso-
ciated with a cardiomyopathy. The sympathetic regulation of the cardiovascular 
system is impaired during the shock. However, involved cellular mechanisms 
are not clear. The aims of this project were to determine the roles of load condi-
tions and β- adrenergic (β- AR) system in cardiac dysfunction in endotoxemic rats.
12 weeks old Sprague Dawley rats received 5mg.kg- 1 of lipopolysaccharide 
(LPS) intravenously. 3h later cardiac parameters were evaluated in vivo, using 
echocardiography, and ex vivo using isolated perfused working heart. β- AR 
responses were studied, both on papillary muscle contractility and sarcomere 
shortening from cardiomyocyte.
In vivo, LPS rats presented altered systolic (shortening fraction - 20.6±3.7% 
vs controls (C) p<0.05) and diastolic (early diastolic peak À ow velocity (E) 
- 47.1±3.9% vs C p<0.05) function. Once isolated, hearts from LPS rats pre-
sented a tachycardia, associated with a decreased diastolic ¿ lling period 
(- 54.4±26.3% vs C p<0.05). LPS hearts also presented a decreased developed 
pressure (- 25.8±4.1% vs C p<0.05) associated with altered dP/dtmax and dP/
dtmin. This results are correlated with a decreased cardiac output (- 27.6±8.1% 
vs C p<0.05). Isoproterenol (iso) (10- 10 to 10- 4 M) induced positive inotropy 
was increased in LPS papillary muscle (+105.2±21.0% vs C p<0.05) albeit 
was similar in LPS and C cardiomyocytes. β1- AR response, performed by 
iso with selective β2 and β3- AR antagonist, was increased both in papillary 
muscles (+93.7±24.6% vs C p<0.05) and cardiomyocytes (+83.5±25.9% vs C 
p<0.05) from LPS rats.
Our hemodynamic results demonstrate a diastolic alteration independent 
of load condition during endotoxemia. Surprisingly, β1- AR response was 
increased in LPS rats and could participate to the tachycardia described in this 
disease. This open new ¿ elds of research to evaluate β1- blockers in the septic 
shock treatment. 
